Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations.

[1]  J. Harwood,et al.  Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa. , 2005, The Journal of antimicrobial chemotherapy.

[2]  D. Coşkun,et al.  Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. , 2005, The Journal of hospital infection.

[3]  S. Perron,et al.  Surgical-Site Infection After Cardiac Surgery: Incidence, Microbiology, and risk Factors , 2005, Infection Control & Hospital Epidemiology.

[4]  Carsten Lührs,et al.  EuroSCORE predicts intensive care unit stay and costs of open heart surgery. , 2004, The Annals of thoracic surgery.

[5]  M. Banbury.  Experience in prevention of sternal wound infections in nasal carriers of Staphylococcus aureus. , 2003, Surgery.

[6]  M. Czerny,et al.  The vacuum-assisted closure system for the treatment of deep sternal wound infections after cardiac surgery. , 2002, The Annals of thoracic surgery.

[7]  J. Vaage,et al.  Postoperative mediastinitis in cardiac surgery - microbiology and pathogenesis. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  D. Spelman,et al.  Cost of surgical site infections following coronary artery bypass surgery , 2001, ANZ journal of surgery.

[9]  D. D. Jaworski,et al.  Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.

[10]  Charles O. Rock,et al.  erratum: A triclosan-resistant bacterial enzyme , 2000, Nature.

[11]  M. Wilcox,et al.  The cost of hospital-acquired infection and the value of infection control. , 2000, The Journal of hospital infection.

[12]  R. Wenzel,et al.  Does the Centers for Disease Control’s NNIS System Risk Index Stratify Patients Undergoing Cardiothoracic Operations by Their Risk of Surgical-Site Infection? , 2000, Infection Control & Hospital Epidemiology.

[13]  Antoni R. Slabas,et al.  Molecular basis of triclosan activity , 1999, Nature.

[14]  Teresa C. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999 , 1999, Infection Control & Hospital Epidemiology.

[15]  T. Neal,et al.  An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus. , 1999, The Journal of hospital infection.

[16]  S. Levy,et al.  Triclosan targets lipid synthesis , 1998, Nature.

[17]  R. El Oakley,et al.  Postoperative mediastinitis: classification and management. , 1996, The Annals of thoracic surgery.

[18]  R W Stewart,et al.  J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. , 1990, The Annals of thoracic surgery.

[19]  S. D. Elek,et al.  The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection. , 1957, British journal of experimental pathology.

[20]  J E García-Sánchez,et al.  Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. , 2007, The Journal of infection.

[21]  R. Wynne,et al.  Effect of three wound dressings on infection, healing comfort, and cost in patients with sternotomy wounds: a randomized trial. , 2004, Chest.

[22]  D. Fry,et al.  The economic costs of surgical site infection. , 2002, Surgical infections.

[23]  Sd. Elek.  The virulence of staph pyogenes for man : a study of wound infection , 1957 .